Skip to main content
logo
TG Therapeutics logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
55.27
-0.10 (-0.18%)
At close: Oct 12, 2026, 4:00 PM EDT
55.26
-0.01 (-0.02%)
Pre-market: Oct 13, 2026, 7:00 AM EDT

TG Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
799.54616.29329233.662.796.69
Revenue Growth
76.08%87.32%40.80%8290.02%-58.36%4300.66%
Gross Profit
658.6515.57290.52219.532.525.9
Operating Income
136.33123.3241.9320.63-218.32-344.77
Net Income
441.49447.1823.3812.67-223.81-348.1
Earnings Per Share
2.772.770.150.09-1.65-2.63
EPS Growth
667.52%1746.67%68.03%---

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product Revenue, Net
785.53606.93313.7392.012.636.54
License
-0.150.15140.150.150.15
Milestone
--12.5---
Royalty
-5.620.8---
Other
-3.591.821.5--
Revenue (Total)
799.54616.29329233.662.796.69

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
552.25141.97311217.51161.68314.76
Total Debt
754.44254.4254.38111.1583.379.41
Net Cash (Debt)
-202.19-112.4356.62106.3678.38235.36
Net Cash Growth
---46.76%35.70%-66.70%-58.16%
Net Cash Per Share
-1.27-0.700.350.720.581.78

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
17.88-24.77-40.52-31.41-176.17-295.63
Capital Expenditures
-0.49-0.21-0.05--0.01-0.4
Free Cash Flow
17.39-24.99-40.56-31.41-176.18-296.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.37%83.66%88.30%93.95%90.48%88.19%
Operating Margin
17.05%20.01%12.74%8.83%-7838.99%-5154.28%
Pretax Margin
12.71%17.43%7.78%5.59%-8036.34%-5204.08%
Profit Margin
55.22%72.56%7.11%5.42%-8036.34%-5204.08%
FCF Margin
2.17%-4.05%-12.33%-13.44%-6326.18%-4425.70%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
19.969.75184.75190.66--
Forward PE
28.8320.2945.21134.45--
PS Ratio
9.817.0713.1310.34568.84371.96